Transcranial magnetic stimulation (TMS) is a non-invasive, FDA-approved therapy that uses brief magnetic pulses to treat ...
A new study suggests accelerated TMS therapy may help repair stress-damaged brain circuits by offering faster relief and new ...
Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial Magnetic Stimulation (TMS) ...
Transcranial magnetic stimulation (TMS) is a noninvasive, FDA-approved therapy that uses brief magnetic pulses to treat depression, particularly in patients who do not respond to medication. Yet scien ...
In a recent study published in the Scientific Reports, a group of researchers evaluated the efficiency, therapeutic efficacy, and patient perceptions of a custom robotic system for transcranial ...
Researchers reveal that TMS repairs depression by regrowing dendritic spines on specific IT neurons in the prefrontal cortex.
BURLINGTON, Mass. and JERUSALEM, Oct. 16, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Transcranial magnetic stimulation (TMS, or "rTMS" for "repetitive TMS") received an indication for treating major depressive disorder in 2008. Since then, research and clinical experience with TMS has ...
Preliminary research suggests that D-cycloserine significantly enhances the effect of Transcranial Magnetic Stimulation (TMS) Trial is planned to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results